Tag

Regenerative Medicine

All articles tagged with #regenerative medicine

health19 hours ago•8 min saved

Regenerative OA Therapies Rebuild Joints in Weeks, Near Clinical Trials

In animal studies, two regenerative approaches—a single injectable that releases medication over months and a biomaterial scaffold that recruits body’s progenitor cells—repaired damaged cartilage and bone within 4–8 weeks, with ARPA-H funding advancing the project toward clinical trials in about 18 months, aiming for affordable, minimally invasive, single-visit therapies that could eventually reduce the need for joint replacement.

via SciTechDaily|

#arpa-h #biomaterials #clinical-trials

health-and-medicine1 day ago•9 min saved

Engineered vitamin K compounds aim to spur brain neuron regrowth

Japanese researchers developed vitamin K analogs linked to retinoic acid that threefold boost the differentiation of neural progenitor cells into neurons and cross the blood–brain barrier in mice, increasing brain MK-4 levels; this points to a regenerative approach for diseases like Alzheimer's and Parkinson’s, though human trials are not yet underway.

via ScienceDaily|

#brain-differentiation #health-and-medicine #neurodegeneration

science8 days ago•2 min saved

Wool-Derived Keratin Membranes Show Promise for Bone Regeneration

Scientists at King’s College London demonstrated that wool-derived keratin membranes can guide bone regeneration in rats with skull defects, yielding bone that is more organized and structurally similar to natural bone than collagen, suggesting a sustainable collagen alternative for regenerative medicine and dental use, though human trials are needed.

via SciTechDaily|

#bone-regeneration #collagen-alternative #keratin

science12 days ago•2 min saved

Serum Sparks Mammal Limb Regrowth, Hinting at Regenerative Medicine

Texas A&M researchers report a two-step, serum-driven process that turns local cells into a blastema and promotes limb-like regeneration in lab mice by first reducing scarring and then providing developmental signals, using resident cells rather than external stem cells; the approach could lessen scarring and broaden understanding of mammalian healing with potential human applications.

via Futurism|

#blastema #epimorphic-regeneration #limb-regeneration

health25 days ago•7 min saved

Human Hearts Show Regrowth After Heart Attacks, Study Finds

New human data confirm that heart muscle cells can regrow after a heart attack, challenging the long-held belief that damage is permanent. By analyzing living heart tissue from bypass patients, researchers observed increased cardiomyocyte mitosis in the damaged regions, suggesting a regenerative process alongside scarring. While not yet reversing heart failure, these findings pave the way for therapies that boost the heart’s natural cell production to repair damage and potentially reduce reliance on transplantation.

via SciTechDaily|

#cardiomyocytes #health #heart

science1 month ago•4 min saved

Soft Tissue Cues Unlock Fingertip Regrowth in Humans

New research shows humans can regrow fingertip tissue—bone, nerves, and skin—when injuries occur near the nail, driven by a soft, hyaluronic acid–rich extracellular matrix; experiments in mice demonstrate hyaluronic acid and ECM components are key to regenerative healing rather than scarring.

via Indian Defence Review|

#extracellular-matrix #fingertip-regeneration #hyaluronic-acid

science1 month ago•6 min saved

Lab-Grown Insulin Cells Restore Blood Sugar in Diabetic Mice

Researchers refined a stem cell protocol to produce mature, glucose-responsive insulin-secreting cells from human pluripotent stem cells. When transplanted into the anterior chamber of the eye in diabetic mice, these cells gradually restored blood-sugar control, addressing earlier issues with maturity and purity and signaling potential for patient-specific regenerative therapies.

via SciTechDaily|

#clinical-translation #diabetes #insulin

science1 month ago•17 min saved

Single-dose injection shows potential to repair arthritic joints in weeks

Animal studies show a single injection can restore arthritic joints to a healthy state within 4–8 weeks, rebuilding cartilage and bone and signaling repair pathways; researchers are also pursuing a patch approach for larger defects, with safety-focused human trials expected by late 2027 under the NITRO program, though a clinic-ready treatment is not yet available.

via Earth.com|

#bone-remodeling #cartilage-repair #joint-injection

healthcare1 month ago•8 min saved

UCB bets on regenerative epilepsy therapy with Neurona buy

UCB to acquire Neurona Therapeutics for up to $1.15 billion ($650 million upfront plus up to $500 million in milestones), adding NRTX-1001, a regenerative neural cell therapy in Phase I/II for drug-resistant mesial temporal lobe epilepsy that aims to restore neural circuitry by delivering GABA-producing cells. The deal underscores UCB’s push into regenerative medicine, with RMAT/PRIME designations reflecting regulatory interest, and is expected to close by the end of Q2 2026, while 2026 revenue and EBITDA guidance remain unchanged.

via UCB|

#healthcare #mesial-temporal-lobe-epilepsy #neurona-therapeutics

science1 month ago•4 min saved

Injectable slow-release therapy reverses osteoarthritis in animal tests

UC Boulder researchers have developed a slow-release injectable therapy that prompts joint cells to repair cartilage and bone, reversing osteoarthritis in animal models within weeks. They’ve completed the first phase of experiments and are moving to safety/toxicity studies to enable human trials—potentially within 18 months—funded by ARPA-H’s NITRO program, as they pursue options beyond pain management and joint replacement.

via ScienceAlert|

#cartilage #clinical-trials #drug-delivery

science2 months ago•6 min saved

A single RNA injection turns muscle into a heart-healing factory

Columbia researchers engineered RNA-lipid nanoparticles that, when injected into skeletal muscle, make pro-ANP. This inactive molecule travels to the heart and is activated by the enzyme Corin to become active ANP, promoting blood vessel growth, reducing inflammation, and limiting scar tissue to help repair the heart after a heart attack. Using self-amplifying RNA, a single injection can sustain activity for about four weeks, improving heart function and reducing damage in multiple animal models, including delayed treatment scenarios. The approach avoids direct heart delivery, offering a potentially simpler therapy with plans for a phase‑one safety trial and potential applications to other organs.

via SciTechDaily|

#myocardial-infarction #pro-anp #regenerative-medicine

biotechnology2 months ago•5 min saved

Lab-grown esophagus in pigs restores swallowing, signaling pediatric repair prospects

Scientists grew lab-made oesophagi from pig stem cells on scaffolds and implanted them into eight recipient pigs. Over two months the grafts developed into functional tissue with nerves, muscle, and blood vessels, and five pigs survived six months, regaining the ability to swallow. While some initial scar tissue affected swallowing, it diminished over time, suggesting a path toward treating conditions like long-gap oesophageal atresia in children or muscular damage in adults, though human trials are still future work.

via Nature|

#biotechnology #oesophagus #pig-model

science2 months ago•7 min saved

Japan Grants World-First Approvals for iPS Cell–Based Therapies in Heart Failure and Parkinson’s

Japan approved two therapies derived from reprogrammed human iPS cells for heart failure and Parkinson’s disease, marking the first global use of iPS-derived cells in approved medical products. The treatments—one applied to the heart surface and the other injected into the brain—entered conditional, time-limited use requiring ongoing safety and effectiveness data after launch, reflecting Japan’s specialized regulatory and manufacturing infrastructure and the ongoing influence of Shinya Yamanaka in the field.

via The Daily Galaxy|

#ips-cells #japan #parkinsons-disease

science2 months ago•6 min saved

Japan Approves First iPS-Cell Therapies for Heart Failure and Parkinson’s

Japan’s health ministry conditionally approved two therapies derived from reprogrammed iPS cells—ReHeart for severe heart failure and Amusepri for Parkinson’s—marking the first medical treatments of this kind and signaling a new era in regenerative medicine, though extended safety and efficacy data from more patients are still needed.

via Indian Defence Review|

#heart-failure #ips-cells #japan

science2 months ago•9 min saved

Japan Approves First iPS Cell–Based Regenerative Therapies for Heart and Parkinson’s

Japan’s health ministry granted conditional, time‑limited approvals to two regenerative medicines derived from donor iPS cells—ReHeart for severe heart failure and Amusepri for Parkinson’s—marking the world’s first market authorizations for iPS‑cell–based therapies. Developed with Kyoto University and Osaka University collaborators, the products will be produced at the SMaRT facility in Suita and require post‑marketing safety and efficacy studies; insurance coverage will follow after regulatory steps. This milestone, tied to the 20th anniversary of mouse iPS cell creation, highlights Japan’s leadership in translating reprogrammed cells into clinical practice.

via WIRED|

#amusepri #induced-pluripotent-stem-cells #japan-approval